AlphaFold predicted structure
DPH1 · Q9BZG8

Mean pLDDT
86.1/ 100
Confident
438 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)2%
- Low(50–70)2%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
diphthamide biosynthesis 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalRare syndromic craniosynostosis or isolated multisuture synostosis
BIALLELIC, autosomal or pseudoautosomaldevelopmental delay with short stature, dysmorphic facial features, and sparse hair 1
developmental delay with short stature, dysmorphic facial features, and sparse hair
neurodegenerative disease
hereditary disease
Global developmental delay
Hydrocephalus
Dandy-Walker syndrome
Cerebellar vermis hypoplasia
intracerebral hemorrhage
arthritic joint disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1
Catalyzes the first step of diphthamide biosynthesis, a post-translational modification of histidine which occurs in elongation factor 2 (PubMed:30877278). DPH1 and DPH2 transfer a 3-amino-3-carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to a histidine residue, the reaction is assisted by a reduction system comprising DPH3 and a NADH-dependent reductase (By similarity). Acts as a tumor suppressor (PubMed:10519411)
DPH1 · Q9BZG8

Mean pLDDT
86.1/ 100
Confident
438 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0